Information  X 
Enter a valid email address

Hardman & Co Research (SIXH)

  Print      Mail a friend       Annual reports

Tuesday 20 November, 2018

Hardman & Co Research

The 600 Group (SIXH): Trading still healthy, with good order book

Hardman & Co Research
Hardman & Co Research: The 600 Group (SIXH): Trading still healthy, with good order book

20-Nov-2018 / 14:15 GMT/BST

Hardman & Co: Trading still healthy, with good order book

The 600 Group remains competitively well positioned, with a world-class reputation in machine tools and laser marking. Around 65% of sales are in the US. Business momentum is good, with a healthy order book, and with growth enhanced by new product launches and new market entry. The shares are attractively valued against the peer group on a DCF basis, and offer an appealing yield.

Please click here for the full report:

To contact us:

Hardman & Co
35 New Broad Street
Follow us on Twitter @HardmanandCo

Paul Singer

+44 20 7194 7622

[email protected]

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the world with high-quality research, investor engagement programmes and advisory services.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

End of Announcement - EQS News Service

748969  20-Nov-2018 


a d v e r t i s e m e n t